Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm | Zendy

Margos Panagiotis | Zendy; Margos Nikolaos | Zendy; Mokadem Nadiya | Zendy; Patsiotis Ilias | Zendy; Kranidis Athanasios | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm

Author(s) -

Margos Panagiotis,

Margos Nikolaos,

Mokadem Nadiya,

Patsiotis Ilias,

Kranidis Athanasios

Publication year - 2017

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.1019

Subject(s) - medicine , ranolazine , cardiomyopathy , storm , cardiology , heart failure , oceanography , geology

Key Clinical Message Among implantable cardioverter‐defibrillator (ICD) recipients, there are patients with recurrent episodes of electrical storm (ES), retractable to the optimal antiarrhythmic drug therapy or invasive ablation procedures. A relatively novel anti‐ischemic drug with also antiarrhythmic properties, ranolazine, may effectively suppress ventricular arrhythmias in such patients for a long period of time.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research